Production (Stage)
AVITA Medical, Inc.
RCEL
$6.28
-$0.12-1.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.35% | 28.14% | 32.24% | 32.53% | 35.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.35% | 28.14% | 32.24% | 32.53% | 35.44% |
| Cost of Revenue | 36.56% | 16.89% | 17.45% | 11.63% | 28.60% |
| Gross Profit | 42.20% | 30.20% | 35.09% | 36.67% | 36.72% |
| SG&A Expenses | 25.70% | 39.25% | 48.53% | 50.78% | 51.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 97.54% | 91.22% | 74.23% |
| Total Operating Expenses | 22.07% | 30.21% | 45.59% | 47.51% | 53.98% |
| Operating Income | -2.50% | -32.65% | -62.30% | -66.20% | -78.82% |
| Income Before Tax | -27.40% | -74.97% | -70.50% | -63.23% | -69.78% |
| Income Tax Expenses | -51.52% | -18.18% | -39.74% | 21.13% | 6.45% |
| Earnings from Continuing Operations | -27.28% | -74.80% | -70.25% | -63.13% | -69.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.28% | -74.80% | -70.25% | -63.13% | -69.63% |
| EBIT | -2.50% | -32.65% | -62.30% | -66.20% | -78.82% |
| EBITDA | -1.03% | -31.96% | -62.38% | -66.68% | -79.79% |
| EPS Basic | -24.60% | -71.18% | -66.94% | -60.25% | -67.03% |
| Normalized Basic EPS | -6.95% | -42.40% | -83.74% | -81.70% | -91.76% |
| EPS Diluted | -24.60% | -70.66% | -66.42% | -59.70% | -66.37% |
| Normalized Diluted EPS | -6.95% | -42.40% | -83.74% | -81.70% | -91.76% |
| Average Basic Shares Outstanding | 2.35% | 2.18% | 1.92% | 1.74% | 1.49% |
| Average Diluted Shares Outstanding | 2.35% | 2.18% | 1.92% | 1.74% | 1.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |